Although the overexpression of ACE2 prevents investigation of long-term consequences of infection due to potential non-specific disease, which is a major limitation of the model, an advantage of these mice is that they develop severe respiratory disease in a virus dose-dependent manner, partially mirroring what is observed in COVID-19 patients45–48. This evidence concerns the gene ACE2 and respiratory system disorder.